Langer A - Search Results

1

Development and prognosis of non-Q-wave myocardial infarction in the thrombolytic era.

Goodman SG, Barr A, Langer A, Wagner GS, Fitchett D, Armstrong PW, Naylor CD. Goodman SG, et al. Among authors: langer a. Am Heart J. 2002 Aug;144(2):243-50. doi: 10.1067/mhj.2002.124059. Am Heart J. 2002. PMID: 12177641

2

Combining baseline clinical descriptors and real-time response to therapy: the incremental prognostic value of continuous ST-segment monitoring in acute myocardial infarction.

Maas AC, Wyatt CM, Green CL, Wagner GS, Trollinger KM, Pope JE, Langer A, Armstrong PW, Califf RM, Simoons ML, Krucoff MW. Maas AC, et al. Among authors: langer a. Am Heart J. 2004 Apr;147(4):698-704. doi: 10.1016/j.ahj.2003.08.014. Am Heart J. 2004. PMID: 15077087

3

One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry).

Yan AT, Tan M, Fitchett D, Chow CM, Fowlis RA, McAvinue TG, Roe MT, Peterson ED, Tu JV, Langer A, Goodman SG; Canadian Acute Coronary Syndromes Registry Investigators. Yan AT, et al. Among authors: langer a. Am J Cardiol. 2004 Jul 1;94(1):25-9. doi: 10.1016/j.amjcard.2004.03.024. Am J Cardiol. 2004. PMID: 15219503

4

Clinical trial--derived risk model may not generalize to real-world patients with acute coronary syndrome.

Yan AT, Jong P, Yan RT, Tan M, Fitchett D, Chow CM, Roe MT, Pieper KS, Langer A, Goodman SG; Canadian Acute Coronary Syndromes registry investigators. Yan AT, et al. Among authors: langer a. Am Heart J. 2004 Dec;148(6):1020-7. doi: 10.1016/j.ahj.2004.02.014. Am Heart J. 2004. PMID: 15632888

5

Early cardiac catheterization is associated with lower mortality only among high-risk patients with ST- and non-ST-elevation acute coronary syndromes: observations from the OPUS-TIMI 16 trial.

Cantor WJ, Goodman SG, Cannon CP, Murphy SA, Charlesworth A, Braunwauld E, Langer A. Cantor WJ, et al. Among authors: langer a. Am Heart J. 2005 Feb;149(2):275-83. doi: 10.1016/j.ahj.2004.05.055. Am Heart J. 2005. PMID: 15846265 Clinical Trial.

6

In-hospital revascularization and one-year outcome of acute coronary syndrome patients stratified by the GRACE risk score.

Yan AT, Yan RT, Tan M, Eagle KA, Granger CB, Dabbous OH, Fitchett D, Grima E, Langer A, Goodman SG; Canadian Acute Coronary Syndromes Registry Investigators. Yan AT, et al. Among authors: langer a. Am J Cardiol. 2005 Oct 1;96(7):913-6. doi: 10.1016/j.amjcard.2005.05.046. Am J Cardiol. 2005. PMID: 16188515

7

Predictors and 1-year outcome of major bleeding in patients with non-ST-elevation acute coronary syndromes: insights from the Canadian Acute Coronary Syndrome Registries.

Segev A, Strauss BH, Tan M, Constance C, Langer A, Goodman SG; Canadian Acute Coronary Syndromes Registries Investigators. Segev A, et al. Among authors: langer a. Am Heart J. 2005 Oct;150(4):690-4. doi: 10.1016/j.ahj.2004.11.012. Am Heart J. 2005. PMID: 16209967

8

Age-related differences in the management and outcome of patients with acute coronary syndromes.

Yan RT, Yan AT, Tan M, Chow CM, Fitchett DH, Ervin FL, Cha JY, Langer A, Goodman SG; Canadian Acute Coronary Syndromes (ACS) Registry Investigators. Yan RT, et al. Among authors: langer a. Am Heart J. 2006 Feb;151(2):352-9. doi: 10.1016/j.ahj.2005.03.039. Am Heart J. 2006. PMID: 16442898

9

Randomized evaluation of the efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Long-term results of the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) trial.

Fitchett DH, Langer A, Armstrong PW, Tan M, Mendelsohn A, Goodman SG; INTERACT Trial Long-Term Follow-Up Investigators. Fitchett DH, et al. Among authors: langer a. Am Heart J. 2006 Feb;151(2):373-9. doi: 10.1016/j.ahj.2005.05.003. Am Heart J. 2006. PMID: 16442903 Clinical Trial.

10

The greatest benefit of enoxaparin over unfractionated heparin in acute coronary syndromes is achieved in patients presenting with ST-segment changes: the Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) Electrocardiogram Core Laboratory Substudy.

Goodman SG, Bozovich GE, Tan M, Dos Santos A, Gurfinkel EP, Cohen M, Langer A; Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. Goodman SG, et al. Among authors: langer a. Am Heart J. 2006 Apr;151(4):791-7. doi: 10.1016/j.ahj.2005.08.007. Am Heart J. 2006. PMID: 16569535

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

851 results

Search Page

Filters